Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Ala-Hurula

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Headache|July 1, 1982
Bioavailability and antimigraine efficacy of effervescent ergotamineV Ala-Hurula
European Journal of Clinical Pharmacology|January 1, 1982
Correlation between pharmacokinetics and clinical effects of ergotamine in patients suffering from migraineV Ala-Hurula
Cephalalgia : an International Journal of Headache|December 1, 1982
Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrationsV Ala-Hurula, V Myllylä, E Hokkanen
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1978
[Ergotamine]V Ala-Hurula, V Myllylä, E Hokkanen
Headache|November 1, 1981
Tolfenamic acid and ergotamine abuseV Ala-Hurula, V V Myllylä, E Hokkanen, et al.
Upsala Journal of Medical Sciences. Supplement|January 1, 1980
Systemic availability of ergotamine tartrate in continuous medicationV V Myllylä, V Ala-Hurula, P Arvela, et al.
European Journal of Clinical Pharmacology|November 1, 1979
Systemic availability of ergotamine tartrate after three successive doses and during continuous medicationV Ala-Hurula, V V Myllylä, P Arvela, et al.
Upsala Journal of Medical Sciences. Supplement|January 1, 1980
Systemic availability of ergotamine tartrate in healthy subjects after single and repeated oral dosesV Ala-Hurula, V V Myllylä, P Arvela, et al.
Acta Neurologica Scandinavica|September 1, 1979
Juvenile amyotrophic lateral sclerosis. A report of two cases in a single familyV V Myllylä, E Toivakka, V Ala-Hurula, et al.
European Journal of Clinical Pharmacology|February 19, 1979
Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administrationV Ala-Hurula, V V Myllylä, P Arvela, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Headache|July 1, 1982
Bioavailability and antimigraine efficacy of effervescent ergotamineV Ala-Hurula
European Journal of Clinical Pharmacology|January 1, 1982
Correlation between pharmacokinetics and clinical effects of ergotamine in patients suffering from migraineV Ala-Hurula
Cephalalgia : an International Journal of Headache|December 1, 1982
Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrationsV Ala-Hurula, V Myllylä, E Hokkanen
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1978
[Ergotamine]V Ala-Hurula, V Myllylä, E Hokkanen
Headache|November 1, 1981
Tolfenamic acid and ergotamine abuseV Ala-Hurula, V V Myllylä, E Hokkanen, et al.
Upsala Journal of Medical Sciences. Supplement|January 1, 1980
Systemic availability of ergotamine tartrate in continuous medicationV V Myllylä, V Ala-Hurula, P Arvela, et al.
European Journal of Clinical Pharmacology|November 1, 1979
Systemic availability of ergotamine tartrate after three successive doses and during continuous medicationV Ala-Hurula, V V Myllylä, P Arvela, et al.
Upsala Journal of Medical Sciences. Supplement|January 1, 1980
Systemic availability of ergotamine tartrate in healthy subjects after single and repeated oral dosesV Ala-Hurula, V V Myllylä, P Arvela, et al.
Acta Neurologica Scandinavica|September 1, 1979
Juvenile amyotrophic lateral sclerosis. A report of two cases in a single familyV V Myllylä, E Toivakka, V Ala-Hurula, et al.
European Journal of Clinical Pharmacology|February 19, 1979
Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administrationV Ala-Hurula, V V Myllylä, P Arvela, et al.
Pageof 2